Masayuki Yokode

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +17

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita, Koutaro Yokote, Hidenori Arai et al. · Journal of Atherosclerosis and Thrombosis · 2018 · 822 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version

Tamio Teramoto, Junichi Sasaki, Shun Ishibashi et al. · Journal of Atherosclerosis and Thrombosis · 2013 · 469 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

<scp>J</scp>apan as the front‐runner of super‐aged societies: Perspectives from medicine and medical care in <scp>J</scp>apan

Hidenori Arai, Yasuyoshi Ouchi, Kenji Toba et al. · Geriatrics and gerontology international/Geriatrics & gerontology international · 2015 · 402 citations

Social Sciences, Demography, Geriatric Medicine +7

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( <i>Srebp2</i> ) regulates HDL in vivo

Takahiro Horie, Koh Ono, Masahito Horiguchi et al. · Proceedings of the National Academy of Sciences · 2010 · 378 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17